[MOL] A phase-1 for INGN241

["Lillian" <firefly@islc.net>]

-----------------------
Introgen Therapeutics of Austin announced that it will begin a
phase-1 trial of INGN241 (Adenoviral-mda7) for solid tumors. The
company expects to enroll 15  patients in a dose-escalating trial of
this adenovirus that targets the mda-7 tumor-suppressor gene. In
preclinical studies the agent suppressed the growth of various types
of cancer cells, according to the company.

 

 

We invite you to take a look at our Album.                                               
www.angelfire.com/sc/molangels/index.html

 

  ( Very informational, good tips, Molers pictures, art work and much more....